CN Stock MarketDetailed Quotes
300246 Guangdong Biolight Meditech
- 7.92
- -0.23-2.82%
Market Closed Dec 13 15:00 CST
2.10BMarket Cap-14.64P/E (TTM)
8.20High7.88Low77.88KlotVolume8.14Open8.15Pre Close62.56MTurnover3.69%Turnover RatioLossP/E (Static)264.58MShares10.7652wk High1.71P/B1.67BFloat Cap5.0752wk Low9.78Limit Up211.30MShs Float47.70Historical High6.52Limit Down3.93%Amplitude3.04Historical Low--Dividend TTM8.03Avg Price42.86KlotAsk--Div YieldTTM100Lot Size34.59KlotBid
Guangdong Biolight Meditech Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -15.15%807.51M | -19.35%536.47M | -22.55%266.86M | 0.87%1.19B | 9.63%951.72M | 19.22%665.23M | 18.09%344.57M | 8.49%1.18B | 10.81%868.12M | 10.16%557.99M |
| Operating revenue | -15.15%807.51M | -19.35%536.47M | -22.55%266.86M | 0.87%1.19B | 9.63%951.72M | 19.22%665.23M | 18.09%344.57M | 8.49%1.18B | 10.81%868.12M | 10.16%557.99M |
| Other operating revenue | ---- | -71.53%4.61M | ---- | -19.00%16.18M | ---- | 61.79%16.19M | ---- | 19.31%19.98M | ---- | 38.83%10.01M |
| Total operating cost | -7.29%836.47M | -9.84%551.81M | -14.40%272.33M | -2.79%1.16B | 4.73%902.22M | 9.51%612.02M | 14.16%318.13M | 16.20%1.19B | 23.02%861.47M | 26.17%558.87M |
| Operating cost | -8.01%588.01M | -10.93%388M | -8.74%193.84M | -2.53%805.51M | 3.98%639.18M | 11.74%435.59M | 7.80%212.4M | 12.49%826.42M | 19.58%614.68M | 20.05%389.84M |
| Operating tax surcharges | -13.14%5.61M | -13.66%3.9M | -34.60%1.87M | 0.29%8.74M | 6.00%6.46M | 10.05%4.52M | 22.52%2.87M | -3.40%8.71M | -2.21%6.09M | -7.80%4.11M |
| Operating expense | -20.94%100.33M | -23.09%68.54M | -30.38%34.35M | -4.21%156.58M | 13.89%126.9M | 20.91%89.12M | 39.70%49.34M | 42.78%163.47M | 57.48%111.43M | 75.15%73.71M |
| Administration expense | 8.93%75.51M | 9.17%48.96M | -3.57%22.63M | -0.70%99.6M | -8.50%69.32M | -14.90%44.84M | -10.77%23.46M | 15.04%100.31M | 26.70%75.76M | 42.30%52.69M |
| Financial expense | 2,754.63%10.53M | 255.19%4.37M | -77.05%1.21M | -67.35%1.49M | 94.50%-396.73K | -22.79%-2.82M | 676.05%5.27M | -14.56%4.56M | -393.22%-7.22M | -152.69%-2.29M |
| -Interest expense (Financial expense) | 91.57%20.74M | 82.45%12.77M | 9.63%3.95M | 29.21%14.88M | 41.15%10.83M | 28.38%7M | 71.93%3.6M | -3.85%11.52M | -25.28%7.67M | -33.57%5.45M |
| -Interest Income (Financial expense) | -29.24%-11.16M | -21.73%-7.09M | -36.16%-3.19M | -99.28%-12.14M | 29.10%-8.63M | 25.63%-5.82M | 31.41%-2.35M | 23.28%-6.09M | -95.10%-12.17M | -102.65%-7.83M |
| Research and development | -7.05%56.48M | -6.70%38.04M | -25.64%18.43M | -1.94%85.85M | 0.06%60.76M | -0.10%40.77M | 33.29%24.79M | 17.77%87.54M | 29.22%60.73M | 34.76%40.81M |
| Credit Impairment Loss | 24.81%-4.12M | 4.84%-3.99M | 73.91%-1.02M | -23.52%-7.79M | -28.94%-5.48M | -38.37%-4.19M | -1,461.05%-3.9M | 13.76%-6.31M | 50.00%-4.25M | 51.80%-3.03M |
| Asset Impairment Loss | 62.37%-614.61K | 97.64%-38.78K | 100.58%10.1K | -4,860.08%-108.79M | -12,635.57%-1.63M | -164,323.09%-1.64M | ---1.75M | 78.20%-2.19M | 98.65%-12.82K | 99.90%-998 |
| Adjustment items of total operating cost | ---- | ---- | ---- | ---- | 175.00%0.06 | ---- | ---- | ---- | ---0.08 | ---- |
| Other net revenue | -30.07%24.16M | -26.39%15.67M | 11.82%10.7M | -288.85%-62.31M | 331.09%34.55M | 202.07%21.29M | 179.25%9.57M | 223.88%33M | 879.47%8.01M | 732.66%7.05M |
| Invest income | -19.01%6.18M | -20.66%4.26M | -12.01%2.34M | 3.28%10.31M | 2,500.72%7.63M | 3,628.88%5.37M | 3,916.29%2.66M | 2,332.93%9.98M | 21.16%-317.85K | 22.15%-152.14K |
| -Including: Investment income associates | -628.57%-962.36K | -571.12%-782.64K | -1,710.84%-637.14K | 85.70%-162.53K | 47.39%-132.09K | 47.03%-116.62K | ---35.18K | -69.66%-1.14M | ---251.09K | ---220.16K |
| Asset deal income | -85.27%-180.64K | -248.11%-208.23K | 80.61%-17.76K | -161.13%-309.52K | -119.18%-97.5K | -85.77%140.59K | -117.83%-91.57K | -45.02%506.32K | 5,946.56%508.34K | --987.89K |
| Other revenue | -32.91%22.9M | -27.59%15.65M | -25.83%9.38M | 42.76%44.27M | 182.35%34.13M | 133.83%21.62M | 369.07%12.64M | 14.48%31.01M | 36.82%12.09M | 44.05%9.25M |
| Operating profit | -105.71%-4.8M | -99.54%341.46K | -85.47%5.23M | -201.58%-26.09M | 473.27%84.05M | 1,106.93%74.5M | 117.53%36M | -66.29%25.68M | -82.15%14.66M | -90.12%6.17M |
| Add:Non operating Income | 1.61%61.1K | -7.83%36.66K | 804.56%24.64K | -85.26%74.76K | -85.22%60.13K | -86.95%39.78K | -76.37%2.72K | -81.01%507.26K | 139.10%406.84K | 143.84%304.72K |
| Less:Non operating expense | -20.66%3.96M | -43.45%2.39M | -95.99%156.86K | 396.88%20.14M | 88.62%4.99M | 573.99%4.23M | 8,636.89%3.91M | 308.64%4.05M | 422.92%2.64M | 109.76%627.98K |
| Total profit | -110.99%-8.7M | -102.87%-2.02M | -84.11%5.1M | -308.50%-46.16M | 536.81%79.12M | 1,101.95%70.31M | 94.29%32.09M | -71.57%22.14M | -84.81%12.42M | -90.61%5.85M |
| Less:Income tax cost | -75.22%2.55M | -111.66%-1.08M | -82.30%669.84K | 695.00%14.8M | 826.05%10.29M | 764.56%9.31M | 71.52%3.79M | -123.43%-2.49M | -90.81%1.11M | -115.22%-1.4M |
| Net profit | -116.34%-11.25M | -101.53%-930.49K | -84.35%4.43M | -347.55%-60.96M | 508.41%68.83M | 741.41%61M | 97.80%28.31M | -63.39%24.62M | -83.77%11.31M | -86.35%7.25M |
| Net profit from continuing operation | -116.34%-11.25M | -101.53%-930.49K | -84.35%4.43M | -347.55%-60.96M | 508.41%68.83M | 741.41%61M | 97.80%28.31M | -63.39%24.62M | -83.77%11.31M | -86.35%7.25M |
| Less:Minority Profit | -47.43%2.39M | -26.01%1.58M | -29.78%803.1K | 69.66%4.23M | 312.62%4.56M | 1,398.51%2.14M | 214.87%1.14M | -28.10%2.49M | 259.37%1.1M | -59.33%142.92K |
| Net profit of parent company owners | -121.22%-13.64M | -104.27%-2.51M | -86.65%3.63M | -394.52%-65.19M | 529.58%64.28M | 728.20%58.86M | 94.75%27.16M | -65.31%22.13M | -85.29%10.21M | -86.53%7.11M |
| Earning per share | ||||||||||
| Basic earning per share | -117.35%-0.0519 | -103.07%-0.0095 | -91.13%0.0137 | -390.93%-0.247 | 403.70%0.2992 | 639.47%0.3091 | 83.06%0.1545 | -80.56%0.0849 | -87.49%0.0594 | -88.42%0.0418 |
| Diluted earning per share | -117.35%-0.0519 | -103.07%-0.0095 | -91.13%0.0137 | -390.93%-0.247 | 403.70%0.2992 | 639.47%0.3091 | 83.06%0.1545 | -80.56%0.0849 | -87.49%0.0594 | -88.42%0.0418 |
| Other composite income | -108.01%-78.55K | -118.49%-485.86K | -212.57%-455.72K | 87.68%2.73M | 172.36%980.57K | 281.93%2.63M | 151.25%404.84K | 128.16%1.46M | -280.48%-1.36M | -1,898.89%-1.44M |
| Other composite income of parent company owners | -108.01%-78.55K | -118.49%-485.86K | -212.57%-455.72K | 87.68%2.73M | 172.36%980.57K | 281.93%2.63M | 151.25%404.84K | 128.16%1.46M | -280.48%-1.36M | -1,898.89%-1.44M |
| Total composite income | -116.22%-11.32M | -102.23%-1.42M | -86.16%3.97M | -323.25%-58.22M | 601.03%69.81M | 995.94%63.63M | 112.35%28.71M | -57.99%26.08M | -85.86%9.96M | -89.08%5.81M |
| Total composite income of parent company owners | -121.02%-13.72M | -104.88%-3M | -88.50%3.17M | -364.76%-62.45M | 636.99%65.26M | 985.78%61.49M | 109.52%27.57M | -59.76%23.59M | -87.38%8.85M | -89.28%5.66M |
| Total composite income of minority owners | -47.43%2.39M | -26.01%1.58M | -29.78%803.1K | 69.66%4.23M | 312.62%4.56M | 1,398.51%2.14M | 214.87%1.14M | -28.10%2.49M | 259.37%1.1M | -59.33%142.92K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
